PURPOSE. Although Epstein-Barr virus (EBV)-associated keratitis is rare, it can cause acute corneal necrosis and neovascularization. We aimed to examine the signaling mechanism by which EBV causes epithelial-mesenchymal transition (EMT) in human corneal epithelial cells (HCECs) in vitro.
H omeostasis of the corneal epithelium is important in the maintenance of normal vision and epithelial tissue integrity. If homeostasis is disturbed by infection, injury, epithelial hypertrophy, or stem cell deficiency, visual impairment can result, which, in turn, can cause corneal fibrosis. Epithelial injury must heal quickly to prevent additional damage from infection. Corneal wound healing involves various cellular systems, including cell migration and proliferation. It generally is accepted that TGF-b1 regulates the diverse events surrounding wound healing.
Epithelial-mesenchymal transition (EMT) is a process that induces cell motility, and increases survival during wound healing and embryogenesis.
1,2 A key mechanism in fibrosis, chronic inflammation, and tumor metastasis, EMT is induced by various growth factors and external stressors, such as TGF-b1, PDGF, EGF, and hypoxia, 2, 3 and is regulated by signaling networks that include Wnt, Notch, PI3K/Akt, Ras/MAPK/Erk, FAK, Smad, and RhoB. 2, 4 The EMT is characterized by a transition from a polarized epithelial phenotype to a mesenchymal phenotype or highly motile fibroblastoid by promoting downregulation of epithelial markers, such as E-cadherin, bcatenin, and ZO-1, as well as upregulation of mesenchymal markers, such as fibronectin, Vimentin, and a-SMA.
1,2
Various transcription factors, including Snail, Slug, TCF8/ Zeb1, and Twist, are known to be capable of regulating EMT in epithelial cells. 2 Recent studies support the notion that Vimentin functions as a positive regulator of EMT. 5 The PI3K/ Akt is known to have a crucial role in actin cytoskeleton remodeling and cell motility in many physiologic processes, including TGF-b1-induced EMT. 6 The PI3K/Akt and Erk have been shown to repress E-cadherin and increase Snail transcription. 7, 8 The TGF-b signals mainly through heteromeric complexes of type I and type II receptors that activate Smad signaling. 9, 10 However, TGF-b responses are not solely the result of the Smad signaling activation, and can, in turn, activate other signaling pathways, such as Erk, p38, MAPK, and JNK. 11, 12 Therefore, the downstream effects of TGF-b should not be considered a direct consequence of the Smad signaling pathway, but instead a result of multiple pathways. The Epstein-Barr virus (EBV), a virus infecting more than 90% of the world's population, is an ubiquitous human herpes virus 4 associated with various lymphoid and epithelial malignancies. 13 Several recent reports suggest that EBV infection may cause phenotypic changes and EMT in several types of epithelial cells. [14] [15] [16] However, the relationship between EBV infection and EMT in primary human corneal epithelial cells (HCECS) remain poorly understood. In this study, we investigated EBV infection and EMT in HCECs.
MATERIALS AND METHODS

Cell Culture and Reagents
Primary HCECs were purchased from Invitrogen-Gibco (Carlsbad, CA). Cells were maintained in keratinocyte serum-free medium (KSFM) supplemented with bovine pituitary extract (Invitrogen-Gibco) and human recombinant epidermal growth factor (Invitrogen-Gibco) at 378C in 5% CO 2 . These cells were maintained for up to 12 passages. LY294002, PD98059, PP1, and Bay-61-3606 were purchased from Calbiochem (San Diego, CA). LY2109761 was obtained from Selleckchem (Houston, TX). Anti-TGF-b1 neutralizing antibody was obtained from R&D Systems (Minneapolis, MN).
Preparation of EBV-Containing Culture Supernatant and Generation of EBV-Infected HCECs
Cell-free EBV-containing culture supernatant was prepared from the B95-8 cell line (EBV type I; ATCC, Manassas, VA). The virus titer of B95-8 EBV was >10 2 transforming units/mL. The transforming units were determined by clumping formation of peripheral mononuclear cells after infection using infectious culture supernatant. 17 After HCECs (passage 3) were completely attached at 6.25 3 10 2 cells/mL in a 75 cm 2 tissue culture flask, an equal volume of EBV-containing culture supernatant (8 mL, >10 2 transforming units/mL) was added. The cultures were incubated between 1 day and 4 weeks. The EBV-infected HCECs were maintained for up to 10 weeks of cultures.
Quantitative Real-Time PCR
Total cellular RNA was isolated using an RNeasy Mini kit (Qiagen, Hilden, Germany) and transcribed into cDNA using oligo (dT) primers and reverse transcriptase 3 weeks after infection. Quantitative mRNA levels were measured by using an ECO real-time PCR system (Illumina, Inc., San Diego, CA) and SYBR Green Master Mix kit (Takara, Tokyo, Japan) with specific primer sets (see Table; Bioneer, Daejeon, Korea).
Immunoblotting
Cells were harvested, lysed, and subjected to SDS-PAGE 4 weeks after infection as described previously. 17 The following primary antibodies were used: phospho-Stat3 (Tyr 
ELISA Test
At 24 hours, the conditioned media were collected, and the quantity of IL-6, IL-8, and MCP-1 secreted by HCECs or EBVinfected HCECs was measured by the Single Analyte ELISArray Kit (Qiagen) according to the manufacturer's instructions. The VEGF, TNF-a, and active TGF-b1 were quantified by the Single cytokine ELISA assay Kit (R&D Systems). Total TGF-b1 was quantified by the LEGEND MAX Total TGF-b1 ELISA Kit (BioLegend, San Diego, CA). Data are expressed as the average of the number of biological replicates 6 SD.
Measurement of Snail and TCF8/Zeb1 Translocation
Cytosol and nuclear cellular fractions were prepared using a Nuclear/Cytosol Fractionation Kit (BioVision, Mountain View, 
CA) according to the manufacturer's instructions 4 weeks after infection. All fractions were stored at À808C until use.
Transendothelial Migration and Invasion Assay
The transendothelial migration of EBV-infected HCECs was detected using CytoSelect tumor transendothelial migration assay Kit (Cell Biolabs, Inc., San Diego, CA) according to the manufacturer's instructions 4 weeks after infection. The relative fluorescence units (RFU) of migrated cells were measured by a microplate reader. The invasion assay was determined using the CultureCoat 96-well Medium BME Cell Invasion Assay Kit (R&D Systems) according to the manufacturer's instructions. Invaded cells were stained with calcein AM and quantified by a microplate reader.
Statistical Analysis
The PCR data, Western blot band, and ELISA data were analyzed statistically. Data were expressed as the mean 6 SD. The statistical significance of differences was tested by KruskalWallis testing using Prism (version 5). Differences were considered significant when P < 0.05.
RESULTS
Detection of EBV-Related Molecules in EBVInfected HCECs
The EBV can infect B cells and epithelial cells. To infect HCECs with EBV, we first determined the presence of the well-known EBV receptors CD21, MHC class II, and integrin b1 by flow cytometry. The HCECs expressed only integrin b1 (data not shown). We established EBV-carrying HCECs showing type IIIlike latency. Typically, the EBV transformation process in B cells is established after 4 weeks. 13 We found that EBV-infected HCECs (EBV-HCECs) changed their shapes from cuboidal and ovoidal to spindle-like within the first week. Cells developed mesenchymal fibroblast-like spindle shapes and lost cell-to-cell contact 3 weeks after EBV infection (Fig. 1B) , while uninfected cells preserved their typical epithelial pebble pattern (Fig. 1A) . The EBV infection was confirmed by real-time PCR and Western blot to detect viral transcripts and proteins, which identified EBNA1, EBNA2, EBNA3A, and LMP1. No EBV-related gene transcripts or proteins were detected in uninfected HCECs (Figs. 1C, 1D ).
EBV Stimulates the Production of ProInflammatory and Pro-Angiogenic Factors
We analyzed mRNA levels and protein levels of pro-inflammatory cytokines and angiogenic factors, and their levels of secretion into the culture supernatant 3 weeks after infection. We found that EBV-HCECs had significantly higher levels of expression of several pro-angiogenic and growth factors compared to uninfected cells: IL-6, IL-8, VEGF, MCP-1, and TNF-a statistically (Figs. 2A, 2B, 3C). In addition, EBV infection increased significantly the mRNA expression of TGF-b1, a wellknown EMT inducer, and induced the secretion of active and total TGF-b1 in HCECs (Figs. 2B, 3A, 3B ). The EBV-HCECs secreted the additional pro-inflammatory and pro-angiogenic factors related to neovascularization, Hif-1a and Stat3, and had increased expression levels of Hif-1a, p-Stat3, and Ang-1 compared to uninfected cells. The Stat3 target genes MMP2 and MMP9 also were upregulated in EBV-HCECs (Figs. 2A, 2B) .
As reported previously, viral infections, such as EBV, elicit the production of cytokines and chemokines in immune cells and tumor cells. 18, 19 Therefore, we hypothesized that the differentiation of HCECs into fibroblast-like cells after EBV infection involved the virus's capability to elicit growth and angiogenic factors. Our results supported our hypothesis.
EBV Induces Dramatic Phenotypic Changes and EMT Characteristics
Several characteristics observed in EBV-HCECs, namely their differentiation into fibroblast-like cells and secretion of TGF-b1, mirror events in EMT, leading us to hypothesize that EBVHCECs were mesenchymal-like cells. To test this hypothesis, we measured the difference in expression of EMT-related markers between EBV-HCECs and uninfected cells. We found that uninfected HCECs expressed primarily the epithelial markers E-cadherin, ZO-1, and b-catenin, with low or absent expression of the mesenchymal markers N-cadherin, Vimentin, Snail, and TCF8/Zeb1 (Fig. 4A) . In contrast, EBV-HCECs expressed high levels of N-cadherin, Vimentin, Snail, and TCF8/Zeb1, but no detectable E-cadherin, ZO-1, or b-catenin (Fig. 4A) . We also observed that expression of the corneal epithelial cell marker np63 was decreased, while expression of the corneal differentiation marker CNX43 was increased in EBV-HCECs compared to uninfected cells (Fig. 4A) .
Regulation of the nuclear localization of transcription factors is a crucial event in response to external stimuli, because transcription factors cannot function until they translocate to the nucleus. 20 We performed immuoblotting to determine that Snail and TCF8/Zeb1 translocated to the nucleus in EBV-HCECs (Fig. 4B) . In contrast, uninfected cells expressed small amounts of cytoplasmic Snail and TCF8/Zeb1, but none was detected in the nucleus. These results suggested that EBV infection activated Snail and TCF8/Zeb1, and resulted in their nuclear translocation, potentially leading to diminished epithelial features, enhanced mesenchymal features, and initiation of EMT. Because cell motility is a major factor regulating cell invasion and metastasis, we examined the effects of EBV infection on cell motility using a migration and invasion assay, which showed a marked increased cell motility and invasiveness in EBV-HCECs compared to uninfected cells (Fig. 4C ).
PI3K/Akt and Erk Signaling Are Required for EBVInduced EMT
To understand further the signaling mechanisms involved in EBV-induced EMT, we examined the activation of PI3K/Akt and Erk signaling by EBV infection. Our results showed that the phosphorylation of PI3K-p85, Akt, and Erk was increased markedly in EBV-HCECs compared to uninfected cells (Fig. 5A) . To confirm the requirement for PI3K/Akt and Erk activation in EBV-induced EMT, we used the PI3K/Akt inhibitor LY294002 (LY) and the Erk inhibitor PD98059 (PD). Pretreatment with LY or PD changed the morphology of EBV-HCECs from fibroblastlike shapes to epithelial pebble-like shapes (Fig. 5B) . In EBVHCECs, the expression of Snail, Vimentin, TCF8/Zeb1, and Ncadherin was significantly inhibited by LY or PD treatment, whereas E-cadherin, ZO-1, and b-catenin were restored (Fig.  5C ). In addition, LY or PD treatment suppressed phospho-Stat3, MMP2, MMP9, and VEGF (Fig. 5D) , and blocked EBV-induced migration and invasion (Fig. 5E ). These finding suggested that PI3K/Akt and Erk signaling have a role in the initiation and maintenance of EMT by EBV infection in HCECs.
Syk and Src Signaling Result in EBV-Induced PI3K/ Akt and Erk Activation, and EMT
Our results showed that phosphorylation of Syk and Src, but not Fyn and Lyn, were remarkably increased in EBV-HCECs compared to uninfected cells (Fig. 6A) . To confirm the requirement for Src and Syk activation in EBV-induced EMT development, we used Src inhibitor PP1 and Syk inhibitor Bay-61-3606. The PP1 or Bay-61-3606 treatment changed the morphology of EBV-HCECs from fibroblast-like shapes to epithelial pebble-like shapes (Fig. 6B) , and inhibited the expression of TCF8/Zeb1, Snail, Vimentin, and N-cadherin, while restoring E-cadherin and b-catenin (Fig. 6C) . The PP1 or Bay-61-3606 treatment suppressed phosphorylated PI3K/Akt and Erk (Fig. 6D) .
Recently, the kinases Src, Fyn, and Lyn have been reported to take part in regulating EMT. [21] [22] [23] Previous reports have shown that EBV induces the activation of Akt, Erk, and Syk in B cells and epithelial cells, 24 and that Akt and Erk are downstream signals from Syk and Src. 25, 26 These previous publications and our data indicated that Src and Syk signaling is upstream from PI3K/Akt and Erk, and may have a role in maintaining EMT in EBV-HCECs.
Inhibition of TGF-b1 Signaling Reverses EMT and Induces Mesenchymal-to-Epithelial Differentiation
To test the functional relevance of the activation of TGF-b1 signaling, we investigated the effect of a dual TGF-b R1/R2 inhibitor (LY2109761) or anti-TGF-b1 neutralizing antibody on the differentiation of EBV-HCECs. We measured the expression of the TGF-b1 pathway component Smad2/3, which was not increased in EBV-HCECs (Fig. 7A) . The LY2109761 or anti-TGFb1 neutralizing antibody treatment changed the morphology of EBV-HCECs from fibroblast-like shapes to epithelial pebble-like shapes (Fig. 7B) and suppressed the expression of TCF8/Zeb1, Snail, Vimentin, and N-cadherin, while restoring E-cadherin and b-catenin (Fig. 7C) . The LY2109761 or anti-TGF-b1 neutralizing antibody treatment inhibited the EBV-induced phosphorylation of Src and Syk (Fig. 7D) . These results suggested that EBV activates Smad-independent pathways and that TGF-b1 has a role in initiating EMT.
DISCUSSION
Corneal fibrosis with pannus formation is the third leading cause of blindness worldwide. Fibrosis is a common pathologic event observed in chronic diseases of the kidney, liver, and lung. It has been reported that the cellular origins of pathogenic fibroblasts include embryogenesis, tissue-specific epithelial cells, and circulating cells. 1, 4 Recent studies have demonstrated EMT in a rabbit limbal explant, 26 as well as in the fibrotic process of human pterygium. 27 Particularly, epithelial keratinization and peculiar subepithelial fibrosis can bring about visual impairment, such as ocular fibrosis with stem cell deficiency. 28 Corneas with stem cell deficiencies are characterized by neovascularization and chronic inflammation.
Usually, the fibrosis events in corneal subepithelium are initiated by inflammatory cytokine-mediated corneal stromal fibroblast activation. 29, 30 In particular, keratitis has been shown to involve the mediators, such as MCP-1, TGF-b1, TNF-a, and VCAM-1. This activation then may lead to transdifferentiation into a-SMA-expressing myofibroblasts. 31 Shrinkage of the stress fibers in myofibroblasts subsequently results in the development of fibrosis. 30, 31 Our results indicated that EBV infection caused enhanced secretion of TGF-b1, MCP-1, IL-6, IL-8, VEGF, and TNF-a (Fig. 3) , and EBV infection increased the cell proliferation compared to normal HCEC cell (data not shown). The expression and secretion of TGF-b1 in HCECs has been controversial. The TGF-b1 mRNA was not expressed in HCEC in the one study 32 ; however, other studies showed that protein and mRNA of TGF-b1 were present. 33, 34 These studies investigated the expression and secretion of TGF-b1 using immunohistochemistry and RT-PCR analysis. We mainly performed the quantitative analysis using real time PCR, Western blotting, and ELISA. Further study is required to clarify the TGF-b1 secretion in uninfected HCECs.
The EMT is believed to have an essential role in several developmental processes, including the initiation of fibrosis, embryogenesis, and tumor progression. [1] [2] [3] The EMT-related signaling pathways are, indeed, critical to understanding corneal fibrosis. Unlike fibrotic sites in other organs, myofibroblasts in the lens result exclusively from EMT. 35 In our study, we found that EBV induced EMT in primary HCECs, as evidenced by an increase in mesenchymal markers and a concomitant decrease in epithelial markers. Different EMT regulators show diverse expression and roles in a variety of cells. In human hepatocytes, Snail, Vimentin, Twist, and Slug are upregulated and associated with EMT progression. 36 In gastric cancer, different patterns of expression of Snail, Zeb2, and Twist according to histologic subtype are reported. 37 Twist and Slug are upregulated and involved in breast cancer progression, whereas Snail is downregulated. 38 In prostate cancer, Snail and Slug cause a decrease in E-cadherin expression, and Twist results in further reduction. 39 More recent studies show that TGF-b induces EMT via upregulation of Snail in retinal pigment epithelial cells 40 and via upregulation of TCF8/Zeb1 in renal tubular epithelial cells. 41 In our study, Snail and TCF8/Zeb1 were clearly overexpressed in EBVHCECs compared to uninfected HCECs (Fig. 4) . These results suggested that Snail and TCF8/Zeb 1 may be involved in EMT processes.
Next, we investigated a signaling cascade that controls inflammatory cytokines and induces EMT. A recent study demonstrated that inflammation-induced cell migration and invasion occur through PI3K/Akt-dependent Snail expression. 42 In addition, the activation of Erk positively regulates the expression of Snail and Slug. 43 We observed that Akt/Erk activation is required for Snail and TCF8/Zeb1 transcription in EBV-HCECs. Moreover, the inhibition of PI3K/Akt and Erk signaling significantly suppressed the expression of Snail and TCF8/Zeb1, migration, and invasion, suggesting that PI3K/Akt and Erk signaling has an essential role for EBV-stabilized Snail and TCF8/Zeb1 expression in EBV-HCECs.
Src kinase has been reported to have a role in EMT initiation, cytoskeleton rearrangement, cell motility, and expression of mesenchymal markers by many stimulators. 44, 45 Src suppression allows restoration of E-cadherin, and inhibits expression of Vimentin 46 and other mesenchymal markers. 45 Syk kinase is associated with cell migration and invasion in various epithelial cells. 47 However, whether Syk and Src are involved in EBV-induced EMT in corneal epithelial cells has not yet been elucidated to our knowledge. Our data showed that EBV activated Src and Syk, and that their inhibition restored Ecadherin, and blocked the expression of Snail, TCF8/Zeb1, and Vimentin (Fig. 6 ), indicating that Src and Syk activation is essential for EBV-induced EMT. We found that EBV-induced EMT was regulated by the production of TGF-b1 followed by the activation of Syk/Src and Akt/Erk. These findings provided a detailed understanding of the TGF-b-Syk/Src-Akt/Erk signaling pathway linking EBV infection to EMT. Furthermore, we proposed Syk/Src and Akt/Erk as potential intervention sites to protect against the EBV-induced corneal injury associated with EMT.
The TGF-b-Smad signaling is a major event in the development of EMT, fibrosis, and corneal scarring, which prompted us to investigate whether Smad is activated by EBV infection. Contrary to our hypothesis, EBV did not induce activation of Smad2/3. The Akt and Erk activation appear to be independent of Smad activation for TGF-b-mediated EMT. 11 Erk is required for the loss of cell-to-cell contact and induction of cell migration capacity by TGF-b. Our data are consistent with a previous study 48 showing that inhibition of TGF-bR activity prevents TGF-b1-induced PI3K/Akt activation (Fig. 7) . Based on our research, we have identified a link between EBV infection and EMT, namely a novel causative mechanism for the growth potential of primary HCECs during viral infection. However, there must be differences between what we found in vitro and the assumption of what is going in vivo. In addition, EBV-induced keratitis and keratoconjunctivitis are rare clinically. Blood-ocular barrier and immunologic balance may contribute to the differences, and EMT-related mechanisms appear to occur in concert with ocular disease progression, including keratitis and oncogenesis. Further study is required to clarify the role of EBV infection in TGF-b1 secretion and EMT. In summary, our findings suggested that an EBV-induced TGF-b1-Syk/Src-Akt/Erk signaling pathway is critical to the malignant and invasive potential of HCECs by promoting EMT, and serves as an attractive therapeutic target for ocular disease (Fig. 8) . This study provided further information to guide therapeutic approaches to block EBVinduced EMT and to treat corneal disease in general.
